Alex Marshall contributes to Alantra’s annual Pharma50 report
Corporate finance firm, Alantra, recently published its annual Pharma50 report looking at the fastest-growing pharmaceutical companies in the UK. It found that the fastest-growing privately-owned pharmaceutical companies have all increased sales by at least 10% in each of their last two financial years.
Alex Marshall, Partner at CIL Management Consultants, contributed to the report, commenting on the heightened interested of private equity within the sector: “This is a rare opportunity to invest in a market where the leading players are generating organic growth of 10% or more each year. It’s an industry that remains reasonably fragmented, plus emerging trends such as digitalisation and the growing importance of health economics are only just getting going.”
You can read the full write-up in consultancy.co.uk.
Return to news